Report
Measles & Rubella Partnership Operational Strategy 2026–2030
The Measles & Rubella Partnership (M&RP) enters the second half of the decade at a critical juncture: the Midterm Review of the Measles & Rubella Strategic Framework 2021–2030 (MRSF), highlights that despite progress between 2021–2024, the world remains off track to achieve measles and rubella elimination by 2030. Persistent immunity gaps, increasing frequency and scale of outbreaks, inequities in access, and a tightening global health financing environment continue to constrain progress.
In response, the M&RP Operational Strategy 2026–2030 (Operational Strategy) has been developed to serva as a focused operational plan for the remainder of the decade, translating recommendations and coursecorrections identified through the Midterm Review of the MRSF into actionable approaches for the M&RP to take forward.
Authors
Languages
- English
Publication year
2026
Type
Report
Categories
- Global initiatives
Diseases
- Measles
- Rubella
Organisations
- Gates Foundation
- Gavi, the Vaccine Alliance
- United Nations Children's Fund (UNICEF)
- United States Centers for Disease Control and Prevention (US CDC)
- World Health Organization (WHO)
Tags
- IA2030
